COMMUNIQUÉS West-GlobeNewswire

Avivagen Announces Positive Results from Swine Trial
15/01/2018
OTTAWA, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a Corporation with a proven and commercially-ready, patent-protected product intended to replace the [...]
Cytovance® Biologics Welcomes Edwin Miranda as Vice President of Quality
15/01/2018
OKLAHOMA CITY, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cytovance® Biologics, Inc., a leading full-service biopharmaceutical contract manufacturer of mammalian and microbial biologics, announces and welcomes Edwin Miranda as [...]
Xbrane Biopharma clarifies information regarding letter of intent with CR Pharma considering Xlucane
15/01/2018
Press release 2018-01-15 Xbrane Biopharma ("Xbrane" or the "Company") signed the 7 th of December 2017 a non-binding letter of intent with the Chinese pharmaceutical company CR Pharma regarding out-licensing of Xlucane [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
15/01/2018
FIT Biotech Oy Company release January 15, 2018 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]
Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm
15/01/2018
Press Release 15 January 2018 Immunicum AB (publ) Initiates Trading of Shares on Nasdaq Stockholm Immunicum AB (publ), a biopharmaceutical company advancing a novel immuno-oncology treatment against a range of solid [...]
Shire granted EU marketing authorization for ADYNOVI® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A
15/01/2018
Shire granted EU marketing authorization for ADYNOVI ® [Antihemophilic Factor (Recombinant), PEGylated] for adults and adolescents with Hemophilia A Marketing Authorization will enable patient access to ADYNOVI [...]
TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601
15/01/2018
PRESS RELEASE TiGenix announces publication in Gastroenterology of 52-week results of the Phase III ADMIRE-CD trial of Cx601 Leuven (BELGIUM) - January 15, 2018, 07:00 CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG [...]
TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601
15/01/2018
COMMUNIQUÉ DE PRESSE TiGenix annonce la publication dans Gastroenterology des résultats de la semaine 52 de l'essai de phase III ADMIRE-CD du Cx601 Louvain (BELGIQUE) - 15 janvier 2018, 07h. CET - TiGenix NV (Euronext [...]
Cannabis Wheaton Income Corp. Launches Kolab Project
15/01/2018
VANCOUVER, British Columbia, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is excited to launch KoLab Project Inc. (“ KoLab [...]
Telix Pharmaceuticals Establishes Japanese Subsidiary, Appoints Key Executives
15/01/2018
MELBOURNE, Australia and KYOTO Japan, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic [...]
Nova Leap Health Corp. Grants Stock Options
12/01/2018
HALIFAX, Novia Scotia, Jan. 12, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or the "Company"), a company focused on the home health care industry, has granted 1,485,000 incentive stock [...]
TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion
12/01/2018
WALTHAM, Mass., Jan. 12, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that it has updated the VARUBI® (rolapitant) injectable emulsion package [...]
Loop Industries Announces Net Loss of $6.7 million for the Third Quarter 2018, including $4.4 million Non-Cash Compensation Costs
12/01/2018
Pilot Plant Expansion to Increase Capacity and Demonstrate Continuous Operations Private Common Stock Issuance of $7 .4 million MONTREAL, Jan. 12, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) (the “ [...]
Transparency notifications pursuant to Article 14 of the Law of May 2, 2007
12/01/2018
REGULATED INFORMATION PRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - January 12, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix [...]
Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
12/01/2018
BERKELEY, Calif., Jan. 12, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that on January 10, 2018 the Compensation Committee of Dynavax’s Board of Directors approved the grant [...]
Supernus Mourns the Loss of Board Member William Nuerge
12/01/2018
ROCKVILLE, Md., Jan. 12, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), It is with great sadness that Supernus announces that William Nuerge, a valued member of its Board of Directors, passed [...]
IBA SA : TRANSPARENCY NOTIFICATION
12/01/2018
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, January 12, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
IBA SA : NOTIFICATION DE TRANSPARENCE
12/01/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 12 janvier 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC
12/01/2018
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC Lille (France), Cambridge (Massachusetts, United States), January 12, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at the [...]

Pages